Z-1263-2020 Class II Terminated
FDA device recall Z-1263-2020 was initiated by Abbott Point Of Care Inc. on Jan 15, 2020 and is designated Class II. Reason for recall: The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards… The recall status is terminated (terminated Mar 2, 2021). Affected quantity: 99,850.
Recall details
- Product Type
- Devices
- Report Date
- Feb 26, 2020
- Initiation Date
- Jan 15, 2020
- Termination Date
- Mar 2, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 99,850
Product description
i-STAT CG4+ cartridge (blue), List No. 03P85-50. UDI (01) 00054749002269 - Product Usage: The i-STAT CG4+ cartridge is intended for the quantitative measurement of lactate, pH, pCO2, and pO2 in venous, arterial or capillary whole blood.
Reason for recall
The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.
Distribution pattern
US Nationwide distribution.
Code information
All lots are affected
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1263-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026